Clinical Trials in Houston

Showing 2021-2040 of 8,625 trials

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

NCT04057040

This is a Phase 2 study with an open-label dose escalation phase followed by a blinded withdrawal phase and an open label extension. The study is designed to monitor the PTG-300 safety profile and to obtain preliminary evidence of efficacy of PTG-300 for the treatment of phlebotomy-requiring polycythemia vera.

Polycythemia Vera

Protagonist Therapeutics, Inc.70 participantsStarted Oct 2019

Phoenix, Arizona, United States • Greenbrae, California, United States • Palo Alto, California, United States +13 more locations

COMPLETEDPhase 3< 1 mile

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

NCT02872116

The main purpose of this study is to compare how long patients with gastric or gastroesophageal junction cancer live after receiving nivolumab and ipilimumab or nivolumab and chemotherapy compared with patients receiving chemotherapy alone.

Gastric CancerGastroesophageal Junction CancerEsophageal Adenocarcinoma

Bristol-Myers Squibb2,031 participantsStarted Oct 2016

Los Angeles, California, United States • San Francisco, California, United States • Aurora, Colorado, United States +176 more locations

Hepcidin Mimetic in Patients With Polycythemia Vera (REVIVE)

Efficacy Study of Nivolumab Plus Ipilimumab or Nivolumab Plus Chemotherapy Against Chemotherapy in Stomach Cancer or Stomach/Esophagus Junction Cancer

Find Trials by Condition in Houston

Aromatase Inhibitors and Weight Loss in Severely Obese Men With Hypogonadism

Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial

Proteomics of Brain Trauma-associated Elevated Intracranial Pressure (ICP)

Phase II Decitabine (DAC) Versus Azacitidine (AZA) in Myelodysplastic Syndrome (MDS)

A Study of GC012F (AZD0120), a CAR T Therapy Targeting CD19 and BCMA in Subjects With Relapsed/Refractory Multiple Myeloma

Phase 3 Study of S-217622 in Prevention of Symptomatic SARS-CoV-2 Infection

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening

POWER UP: Participating Online While Exercising to Recover Using Play

Trajectories of Recovery After Intravenous Propofol Versus Inhaled VolatilE Anesthesia Trial

A Comparison of PT027 vs PT007 Used as Needed in Participants With Asthma

A Phase 2 Safety and Efficacy Study of Tulisokibart (MK-7240/PRA023) in Subjects With Moderately to Severely Active Ulcerative Colitis (MK-7240-005)

Dipraglurant (ADX48621) for the Treatment of Patients With Parkinson's Disease Receiving Levodopa-based Therapy

Screening for AL Amyloidosis in Smoldering Multiple Myeloma

Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Relapsed or Refractory Advanced Non-Small Cell Lung Cancer With an FGFR Alteration

A Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of Upadacitinib in Pediatric Subjects With Polyarticular Course Juvenile Idiopathic Arthritis

A Study to Learn How the Study Medicine Danuglipron is Taken Up Into the Blood and If Danuglipron Changes How the Body Processes Other Study Medicines (Atorvastatin and Rosuvastatin) in Healthy Adults Who Are Overweight or Obese

Prolonged Overnight Fasting and/or Exercise on Fatigue and Other Patient Reported Outcomes in Women With Hormone Receptor Positive Advanced Breast Cancer